IE44866L - Halogenated-16ó-methylpregnanes - Google Patents

Halogenated-16ó-methylpregnanes

Info

Publication number
IE44866L
IE44866L IE770462A IE46277A IE44866L IE 44866 L IE44866 L IE 44866L IE 770462 A IE770462 A IE 770462A IE 46277 A IE46277 A IE 46277A IE 44866 L IE44866 L IE 44866L
Authority
IE
Ireland
Prior art keywords
march
methylpregnanes
halogenated
gb1530975a
liy
Prior art date
Application number
IE770462A
Other versions
IE44866B1 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IE44866L publication Critical patent/IE44866L/en
Publication of IE44866B1 publication Critical patent/IE44866B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1530975 9,11 - Dihalo - 16 - methyl steroids ROUSSEL UCLAF 2 March 1977 [2 March 1976] 08713/77 Heading C2U The invention comprises compounds of formula (wherein L is H or C 1-18 acyl, and either X is Cl or Br and Y is Cl, or X is Cl and Y is F); and their preparation from the corresponding 9(11)- enes by halogenation, e.g. with an N-X-succinimide or -acetamide in conjunction with HY or LiY, optionally followed by acylation/deacylation interconversions at C-21. Topical anti-inflammatory compositions comprise a compound I and a carrier. [GB1530975A]
IE462/77A 1976-03-02 1977-03-02 New halogenated derivatives of the 16a-methylpregnane series,processes for preparing them and pharmaceutical compositions containing them IE44866B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (en) 1976-03-02 1976-03-02 NEW HALOGEN DERIVATIVES OF THE 16A-METHYL PREGNANE SERIES

Publications (2)

Publication Number Publication Date
IE44866L true IE44866L (en) 1977-09-02
IE44866B1 IE44866B1 (en) 1982-04-21

Family

ID=9169832

Family Applications (1)

Application Number Title Priority Date Filing Date
IE462/77A IE44866B1 (en) 1976-03-02 1977-03-02 New halogenated derivatives of the 16a-methylpregnane series,processes for preparing them and pharmaceutical compositions containing them

Country Status (16)

Country Link
JP (1) JPS52106855A (en)
AT (1) AT355237B (en)
AU (1) AU509948B2 (en)
BE (1) BE851944A (en)
CA (1) CA1082170A (en)
CH (1) CH619969A5 (en)
DE (1) DE2709078C2 (en)
DK (1) DK156401C (en)
FR (1) FR2342738A1 (en)
GB (1) GB1530975A (en)
IE (1) IE44866B1 (en)
LU (1) LU76867A1 (en)
NL (1) NL7702166A (en)
PT (1) PT66261B (en)
SE (1) SE7702250L (en)
ZA (1) ZA771078B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (en) * 1979-07-26 1981-02-13 Roussel Uclaf NEW HALOGENIC DERIVATIVE OF THE 16A-METHYL PREGNANE SERIES, PREPARATION METHOD AND APPLICATION AS MEDICINE
FR2533928A1 (en) * 1982-10-05 1984-04-06 Roussel Uclaf NOVEL DICHLORIC DERIVATIVES OF THE 16A-METHYL PREGNANE SERIES, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
DE4433374A1 (en) * 1994-09-20 1996-03-21 Hoechst Ag 17-deoxi-corticosteroid-21- / O / -carboxylic acid ester, process for their preparation and medicaments containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928302A (en) * 1958-06-20 1963-06-12 Scherico Ltd í¸-pregnene compounds
US3049554A (en) * 1959-06-01 1962-08-14 Schering Corp 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture

Also Published As

Publication number Publication date
IE44866B1 (en) 1982-04-21
DK156401B (en) 1989-08-14
ZA771078B (en) 1978-04-26
GB1530975A (en) 1978-11-01
CH619969A5 (en) 1980-10-31
DE2709078A1 (en) 1977-09-08
NL7702166A (en) 1977-09-06
FR2342738B1 (en) 1979-10-12
AU2280877A (en) 1978-09-07
FR2342738A1 (en) 1977-09-30
AU509948B2 (en) 1980-06-05
SE7702250L (en) 1977-09-03
BE851944A (en) 1977-09-01
JPS6150960B2 (en) 1986-11-06
JPS52106855A (en) 1977-09-07
ATA136577A (en) 1979-07-15
DK88277A (en) 1977-09-03
CA1082170A (en) 1980-07-22
DK156401C (en) 1990-01-08
DE2709078C2 (en) 1986-09-11
PT66261B (en) 1979-01-17
LU76867A1 (en) 1977-09-26
PT66261A (en) 1977-04-01
AT355237B (en) 1980-02-25

Similar Documents

Publication Publication Date Title
AU543237B2 (en) Anti-cancer quinazoline derivatives
AU521524B2 (en) Quinazoline derivatives
AU498925B2 (en) Quinazoline derivatives
AU5238886A (en) Bicyclic heteroaryl thiazole compounds, cardiotonic compositions including the same, and their uses
AU518957B2 (en) Cataphoretically depositable coating composition
AU506317B2 (en) Quinazoline derivatives
IE44473L (en) 6,9,21-trihalo pregnanes
AU499726B2 (en) Coat liquifaction
AU526270B2 (en) Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives
AU5528380A (en) Tricyclic pyrazole derivatives and their use as anti- inflammatory agents
IE44937L (en) 4-hydroxy-aporphine derivatives
AU506410B2 (en) Quinazoline derivatives
IE44866L (en) Halogenated-16ó-methylpregnanes
AU512947B2 (en) Quinazoline derivatives
NO771804L (en) PROCEDURES FOR THE PREPARATION OF ASSYMETRIC 1,3-DISUBSTITUTED NITROSOUREA DERIVATIVES
AU6738587A (en) Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
IE831145L (en) Pyridine derivatives
AU5933980A (en) Imidazo(2,1-b)quinazoline derivatives
AU526589B2 (en) Cooling dustlike or fine-grained solids
AU6319080A (en) Quinazoline derivatives
AU521096B2 (en) Pyrido [2, 1-b] quinazoline derivatives
IE780546L (en) 1,2-methylene steroids
AU533427B2 (en) Substituted 2(1h) quinazolinones
AU507828B2 (en) Quinazoline derivatives
EP0335369A3 (en) New anthracycline derivatives and processes for the preparation of the same